Medtech

Medtech

GIC joins consortium to invest US$418 mil in biopharmaceutical company I-MAB

Singapore’s sovereign wealth fund, GIC, has joined a consortium of investors to invest US$418 million ($570.2 million), in clinical stage biopharmaceutical company I-MAB.

Be informed of the stories that matter